Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 14 Aug 2002 |
| Novozymes, Novozymes acquires activities in the company InterBio | 2 Jul 2002 |
| Novozymes, acquires George A. Jeffreys | 12 Jun 2002 |
| Novozymes, acquires the activities of BioGaia Fermentation | 3 Jun 2002 |
| Novozymes, licenses hyaluronic acid technology from Hyalose LLC | 13 May 2002 |